Corrigendum

Corrigendum to Anderson et al. Proposed diagnostic and treatment paradigm for high-grade neurological complications of immune checkpoint inhibitors. Neurooncol Pract (doi:10.1093/nop/npy039) first published online October 4, 2018.

The authors of this article wish to correct a dosage in Figure 1 (see new figure). The correct dosage of pyridostigmine should be 30 mg three times per day instead of 30 g. All other dosages in the figure and text are accurate.

Fig. 1.